Novo Nordisk opens Boston office: "Bring us good assets and we'll find the money"

Novo Nordisk is on the hunt for collaborations and purchases for the company's pipeline from a newly opened office in Boston. The office has no concrete budget, just a goal of strengthening and diversifying Novo Nordisk's product range.

John McDonald is head of Novo Nordisk's newly opened biotech office in Boston. Photo: Novo Nordisk/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles